Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Vaccinex stock

Learn how to easily invest in Vaccinex stock.

Vaccinex is a biotechnology business based in the US. Vaccinex shares (VCNX) are listed on the NASDAQ and all prices are listed in US Dollars. Vaccinex employs 39 staff and has a trailing 12-month revenue of around $50,000.

How to buy Vaccinex stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – VCNX. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Vaccinex stock price (NASDAQ: VCNX)

Use our graph to track the performance of VCNX stocks over time.

Vaccinex shares at a glance

Information last updated 2023-01-26.
Latest market close$0.60
52-week range$0.41 - $2.28
50-day moving average $0.61
200-day moving average $0.88
Wall St. target price$7.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.63

Buy Vaccinex stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Vaccinex stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Vaccinex price performance over time

Historical closes compared with the close of $0.6 from 2023-01-27

1 week (2023-01-24) 0.02%
1 month (2022-12-30) -6.25%
3 months (2022-10-31) 1.01%
6 months (2022-07-29) -42.86%
1 year (2022-01-27) N/A
2 years (2021-01-29) -74.58%
3 years (2020-01-31) 6.945
5 years (2018-01-27) N/A

Vaccinex financials

Revenue TTM $50,000
Gross profit TTM $-16,260,000
Return on assets TTM -106.64%
Return on equity TTM -212.74%
Profit margin 0%
Book value $0.15
Market capitalisation $28.9 million

TTM: trailing 12 months

Vaccinex share dividends

We're not expecting Vaccinex to pay a dividend over the next 12 months.

Vaccinex share price volatility

Over the last 12 months, Vaccinex's shares have ranged in value from as little as $0.41 up to $2.28. A popular way to gauge a stock's volatility is its "beta".

VCNX.US volatility(beta: 1.07)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vaccinex's is 1.0744. This would suggest that Vaccinex's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Vaccinex overview

Vaccinex, Inc. , a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through the inhibition of semaphorin 4D (SEMA4D). The company's lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that prevents immune infiltration into tumors and triggers inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. It has also developed a proprietary drug discovery platform, ActivMAb that it is leveraging through strategic collaborations, by exploiting its unique capability to select antibodies against multi-pass membrane receptors. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York.

Frequently asked questions

What percentage of Vaccinex is owned by insiders or institutions?
Currently 14.361% of Vaccinex shares are held by insiders and 55.072% by institutions.
How many people work for Vaccinex?
Latest data suggests 39 work at Vaccinex.
When does the fiscal year end for Vaccinex?
Vaccinex's fiscal year ends in December.
Where is Vaccinex based?
Vaccinex's address is: 1895 Mount Hope Avenue, Rochester, NY, United States, 14620
What is Vaccinex's ISIN number?
Vaccinex's international securities identification number is: US9186401033
What is Vaccinex's CUSIP number?
Vaccinex's Committee on Uniform Securities Identification Procedures number is: 918640103

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site